Fiorini C.; Massari F.; Pedron S.; Sanavio S.; Ciccarese C.; Porcaro A.B.; Artibani W.; Bertoldo F.; Zampini C.; Sava T.; Ficial M.; Calio A.; Chilosi M.; D'Amuri A.; Sanguedolce F.; Tortora G.; Scarpa A.; Delahunt B.; Porta C.; Martignoni G.; Brunelli M., Methods to identify molecular expression of mTOR pathway: A rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors, «AMERICAN JOURNAL OF CANCER RESEARCH», 2014, 4, pp. 907 - 915 [Scientific article]
Pilotto S.; Di Maio M.; Peretti U.; Kinspergher S.; Brunelli M.; Massari F.; Sperduti I.; Giannarelli D.; De Marinis F.; Tortora G.; Bria E., Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2014, 90, pp. 135 - 145 [Scientific article]
Massari F.; Ciccarese C.; Porcaro A.B.; Ferrero S.; Gazzano G.; Artibani W.; Modena A.; Bria E.; Sava T.; Calio A.; Novara G.; Ficarra V.; Chilosi M.; Martignoni G.; Bosari S.; Cheng L.; Tortora G.; Brunelli M., Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma, «PATHOLOGY», 2014, 46, pp. 523 - 526 [Scientific article]
Bianconi M.; Santoni M.; Massari F.; Faloppi L.; Prete M.D.; Giampieri R.; Ciccarese C.; Modena A.; Tortora G.; Scartozzi M.; Cascinu S., Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice, «FUTURE ONCOLOGY», 2014, 10, pp. 2103 - 2106 [Scientific article]
Massari F.; Bria E.; Maines F.; Milella M.; Giannarelli D.; Cognetti F.; Pappagallo G.; Tortora G.; Porta C., Adjuvant treatment for resected renal cell carcinoma: Are all strategies equally negative? Potential implications for trial design with targeted agents, «CLINICAL GENITOURINARY CANCER», 2013, 11, pp. 471 - 476 [Scientific article]
Rosa R.; Damiano V.; Nappi L.; Formisano L.; Massari F.; Scarpa A.; Martignoni G.; Bianco R.; Tortora G., Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer, «BRITISH JOURNAL OF CANCER», 2013, 109, pp. 686 - 693 [Scientific article]
Massari F.; Maines F.; Modena A.; Brunelli M.; Bria E.; Artibani W.; Martignoni G.; Tortora G., Castration resistant prostate cancer (CRPC): State of the art, perspectives and new challenges, «ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY», 2013, 13, pp. 872 - 886 [Scientific article]
Buti, Sebastiano; Bersanelli, Melissa; Sikokis, Angelica; Maines, Francesca; Facchinetti, Francesco; Bria, Emilio; Ardizzoni, Andrea; Tortora, Giampaolo; Massari, Francesco, Chemotherapy in metastatic renal cell carcinoma today? A systematic review, «ANTI-CANCER DRUGS», 2013, 24, pp. 535 - 554 [Scientific article]
Bria E.; Bonomi M.; Pilotto S.; Massari F.; Novello S.; Levra M.G.; Tortora G.; Scagliotti G., Clinical meta-analyses of targeted therapies in adenocarcinoma, «TARGETED ONCOLOGY», 2013, 8, pp. 35 - 45 [Scientific article]
Iacovelli R.; Carteni G.; Sternberg C.N.; Milella M.; Santoni M.; Di Lorenzo G.; Ortega C.; Sabbatini R.; Ricotta R.; Messina C.; Lorusso V.; Atzori F.; De Vincenzo F.; Sacco C.; Boccardo F.; Valduga F.; Massari F.; Baldazzi V.; Cinieri S.; Mosca A.; Ruggeri E.M.; Berruti A.; Cerbone L.; Procopio G., Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort, «EUROPEAN JOURNAL OF CANCER», 2013, 49, pp. 2134 - 2142 [Scientific article]
Santoni M.; Massari F.; Amantini C.; Nabissi M.; Maines F.; Burattini L.; Berardi R.; Santoni G.; Montironi R.; Tortora G.; Cascinu S., Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma, «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2013, 62, pp. 1757 - 1768 [Scientific article]
Brunelli M.; Manfrin E.; Bria E.; Massari F.; Tortora G.; Brunello E.; Carbognin L.; Nottegar A.; Furlanetto J.; Molino A.; Fiorio E.; Chilosi M.; Jasani B.; Vergine M.; Marcolini L.; Filippini D.; Scarpa A.; Martignoni G.; Bonetti F., HER2/neu gene determination in women screened for breast carcinoma: How screening programs reduce the skyrocketing cost of targeted therapy, «ANTICANCER RESEARCH», 2013, 33, pp. 3705 - 3710 [Scientific article]
Pilotto S.; Bria E.; Peretti U.; Massari F.; Garassino M.; Pelosi G.; Tortora G., Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number, «JOURNAL OF THORACIC ONCOLOGY», 2013, 8, pp. 105 - 106 [Scientific article]
Pilotto S.; Peretti U.; Novello S.; Rossi G.; Milella M.; Giaj Levra M.; Ciuffreda L.; Massari F.; Brunelli M.; Tortora G.; Bria E., PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: Translating science into medicine, «EXPERT OPINION ON PHARMACOTHERAPY», 2013, 14, pp. 597 - 608 [Scientific article]
De Bari B.; Fiorentino A.; Greto D.; Ciammella P.; Arcangeli S.; Avuzzi B.; D'Angelillo R.M.; Desideri I.; Kirienko M.; Marchiori D.; Massari F.; Fundoni C.; Franco P.; Filippi A.R.; Alongi F., Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting, «TUMORI», 2013, 99, pp. 637 - 649 [Scientific article]
